Literature DB >> 20068126

Limitations of the Hamilton Anxiety Rating Scale as a primary outcome measure in randomized, controlled trials of treatments for generalized anxiety disorder.

Naomi Koerner, Martin M Antony, Michel J Dugas.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20068126     DOI： 10.1176/appi.ajp.2009.09091264

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

1.  Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.

Authors:  Jamie C Kennedy; Boadie W Dunlop; Linda W Craighead; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  J Consult Clin Psychol       Date:  2018-02

2.  Psychometric Properties of the Reconstructed Hamilton Depression and Anxiety Scales.

Authors:  Eliora Porter; Dianne L Chambless; Kevin S McCarthy; Robert J DeRubeis; Brian A Sharpless; Marna S Barrett; Barbara Milrod; Steven D Hollon; Jacques P Barber
Journal:  J Nerv Ment Dis       Date:  2017-08       Impact factor: 2.254

Review 3.  Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.

Authors:  David S Baldwin; Ruihua Hou; Robert Gordon; Nathan T M Huneke; Matthew Garner
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

4.  Combining computerized home-based treatments for generalized anxiety disorder: an attention modification program and cognitive behavioral therapy.

Authors:  Nader Amir; Charles T Taylor
Journal:  Behav Ther       Date:  2011-05-30

5.  Thinking of Me or Thinking of You? Behavioral Correlates of Self vs. Other Centered Worry and Reappraisal in Late-Life.

Authors:  Akiko Mizuno; Helmet Talib Karim; Jordyn Newmark; Faiha Khan; Matthew Joseph Rosenblatt; Alyssa M Neppach; MaKayla Lowe; Howard Jay Aizenstein; Douglas S Mennin; Carmen Andreescu
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

6.  Commentary. Toward a core outcomes assessment set for clinical high risk.

Authors:  Scott W Woods; Catalina V Mourgues-Codern; Albert R Powers
Journal:  Schizophr Res       Date:  2020-05-12       Impact factor: 4.939

7.  Anxiety Symptoms Questionnaire (ASQ): development and validation.

Authors:  Amanda Baker; Naomi Simon; Aparna Keshaviah; Amy Farabaugh; Thilo Deckersbach; John J Worthington; Elizabeth Hoge; Maurizio Fava; Mark P Pollack
Journal:  Gen Psychiatr       Date:  2019-12-18

8.  SIGH, what's in a name? An examination of the factor structure and criterion validity of the (Structured Interview Guide for the) Hamilton Anxiety scale (SIGH-A) in a sample of African American adults with co-occurring trauma experience and heavy alcohol use.

Authors:  Russell M Marks; Melanie E Bennett; Janet B W Williams; Emma L DuMez; Daniel J O Roche
Journal:  Exp Clin Psychopharmacol       Date:  2021-07-22       Impact factor: 3.492
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.